Investment Firm
Overview
Antegenes is a digital health company implementing advanced genetic tests for personalized prevention of cancer and other complex diseases.
Aug 02, 2022
Seed
Highlights
Location
Social
Investor Lead
N/A
Participant Investors
1
Investor Name |
---|
Timo Rein |
Antegenes raised $1625058 on 2022-08-02 in Seed Round
Antegenes is a digital health company implementing advanced genetic tests for personalized prevention of cancer and other complex diseases.
Company Funding History
4
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Nov 10, 2021 | Pre Seed Round - Antegenes | - | 574.3K | |
Feb 01, 2018 | Angel Round - Antegenes | - | 312.8K | |
Aug 02, 2022 | Seed Round - Antegenes | 4 | - | 1.6M |
Aug 02, 2022 | Grant - Antegenes | 2 | - | 711.0K |
Recent Activity
There is no recent news or activity for this profile.